ERBB2 and breast carcinoma: Similarly, herceptin, an antibody that inhibits human epidermal growth factor receptor 2 (HER2) on HER2-positive breast cancers (Eisenhauer, 2001; Slamon et al., 2001) is also selective and effective, but like Gleevec this is an exception in oncology.